ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS


Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Release: FDA Grants Fast Track Designation For BCX4161 For The Treatment Of Hereditary Angioedema 1/26/2015 7:29:09 AM
Biocryst Pharmaceuticals (BCRX) Receives Positive Opinion On European Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema 1/14/2015 5:51:09 AM
Biocryst Pharmaceuticals (BCRX) To Present At J.P. Morgan Healthcare Conference 1/6/2015 9:54:15 AM
Biocryst Pharmaceuticals (BCRX) Announces The Appointment Of Lynne Powell As Chief Commercial Officer 1/5/2015 7:17:36 AM
Biocryst Pharmaceuticals (BCRX) Receives Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema 12/24/2014 7:53:53 AM
Biocryst Pharmaceuticals (BCRX) Announces Study Results For BCX4430 In A Non-Human Primate Model Of Ebola Virus Infection 12/23/2014 7:44:03 AM
Biocryst Pharmaceuticals (BCRX)'s RAPIVAB™ (Peramivir Injection) Receives FDA Approval For The Treatment Of Acute Uncomplicated Influenza 12/22/2014 6:15:01 AM
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab 12/22/2014 6:13:58 AM
Biocryst Pharmaceuticals (BCRX) Initiates Opus-2: A Clinical Trial Of BCX4161 In Patients With Hereditary Angioedema 12/18/2014 7:41:07 AM
Biocryst Pharmaceuticals (BCRX) Announces Initiation Of A Phase 1 Clinical Trial Of BCX4430 For The Treatment Of Hemorrhagic Fever Viruses 12/15/2014 7:21:55 AM
12345678910...